Please assess the completion status of the following clinical trial:

Trial Title: GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers over 18 years of age.~Exclusion Criteria:~* Any medical condition.~* Any drug treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- GLP-1 (Type: EXPERIMENTAL): Intravenous infusion of GLP-1 at 0.7 and 1.2 mol/kg per minute
- Control (Type: PLACEBO_COMPARATOR): Intravenous saline

Based on this trial design, predict the completion outcome and termination type (if applicable).